Percutaneous Transluminal Coronary Angioplasty (PTCA) Products - Global Strategic Business Report

  • ID: 1946777
  • Report
  • Region: Global
  • 391 Pages
  • Global Industry Analysts, Inc
1 of 4
This report analyzes the worldwide markets for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products in US$ Million by the following product types: Balloon Catheters, Guiding Catheters, and Guide Wires. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. A six-year historic analysis is also provided for these markets.

The report profiles 34 companies including many key and niche players such as Abbott Vascular, C. R. Bard, Inc., Cordis Corporation, Goodman Co., Ltd., Medtronic, Inc., and Terumo Corporation. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.

For information on site licence pricing please click on Enquire before buying
Note: Product cover images may vary from those shown
2 of 4
PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) PRODUCTS

A GLOBAL STRATEGIC BUSINESS REPORT

CONTENTS

1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 1
Study Reliability and Reporting Limitations 1
Disclaimers 2
Data Interpretation & Reporting Level 3
Quantitative Techniques & Analytics 3
Product Definitions and Scope of Study 3
Angioplasty 3
PTCA Devices 4
PTCA Balloon Catheter 4
PTCA Guide Wires 4
PTCA Guiding Catheters 4

2. INDUSTRY OVERVIEW 5
Market Primer 5
Current & Future Analysis 5
Recession Decelerates Growth in PTCA Products Market 5
Rising Incidence and Prevalence of CHD - A Major Growth Driver 6
Complexity of Older Angioplasty Procedures Drive the
Development of Sophisticated Angioplasty Devices 6
Vagaries Exist Among Adoption of Revascularization Procedures
Worldwide 6
Table 1: Global Angioplasty Procedural Volume (2009-2012):
Number of Procedures in Thousands for US, Japan and Rest of
World (includes corresponding Graph/Chart) 7
Angioplasty versus CABG - The Debate on the Most Effective
Procedure Continues 7
Drug-Eluting Balloons (DEBs) - A New Advancement in
Intravascular Procedures 8
Few Products on the Market, Many More to Come 9
Select Marketed and Development-Stage Drug-Eluting Balloon
Products 9
Expanded Applications to Fortify Demand for Drug Eluting
Balloons 9
Peripheral Arterial Disease Augurs More Prospects for Drug-
Eluting Balloons 10
Promise of Major Benefits Draws Widespread Interest 10
Drug-Eluting Balloons - A Threat to Drug-Eluting Stents in
Coronary Procedures? 11
Safety Concerns on Drug-Eluting Stents Open Window of
Opportunity for Drug-Eluting Balloons 11
Paclitaxel Remains the Most Sought-After Drug for DEBs 12

3. COMPETITIVE LANDSCAPE 13
Boston Scientific Corp. - A Leading Global Player in the
Angioplasty Market 13
Bard Fortifies Market Share, Eyes No. 1 Spot in Peripheral PTA
Market 13

4. STENTING 14
Stent - A Key Support Device in Angioplasty 14
Concerns over Restenosis Post-Angioplasty Drives Use of Stents 14
Stents - Types and Application 14
A Peek into Peripheral Vascular Stents Market 15
Lack of Awareness Limits Growth 15
Table 2: Global Peripheral Vascular Stents Market by
Region: Percentage Breakdown of Revenues for US, Europe and
Asia-Pacific (includes corresponding Graph/Chart) 15
Coronary Stents Market - An Overview 16
Aging Population, New Technologies to Boost Market for
Coronary Stents 16
Table 3: Global Coronary Stents Market by Region: Percentage
Breakdown of Revenues for Europe, US, Asia-Pacific and Rest
of World (includes corresponding Graph/Chart) 16
A Brief Insight into the Drug Eluting Stents Market 16
Table 4: Global Drug-Eluting Stents Market by Product Type
(2010): Percentage Breakdown of Unit Sales and Revenues for
Coronary Stents and Others (includes corresponding
Graph/Chart) 17
Concerns Over Safety and Cost Restrain Adoption of DES 18
Intensifying Competition in the DES Space 18
Table 5: Global Drug-Eluting Stents Market (2009-2012):
Market Share Breakdown of Value Sales for Abbott
Laboratories, Boston Scientific, Medtronic, Johnson &
Johnson and Others (includes corresponding Graph/Chart) 19

5. PRODUCT OVERVIEW 20
Introduction 20
What Can Angioplasty Do? 20
An Overview of Angioplasty Procedure 20
Types of Angioplasty Procedures 21
Balloon Angioplasty 21
Advantages of Angioplasty 21
Major Disadvantages 22
Stenting 22
Laser Angioplasty 22
Atherectomy 23
Cutting Balloon 23
Limitations of the Angioplasty Procedure 23
Risk Factors in Angioplasty Procedures 23
Balloon Angioplasty Devices 24
Balloon Catheters 24
Guide Wires 24
Guiding Catheters 24

6. PRODUCT INNOVATIONS/INTRODUCTIONS 25
Boston Scientific to Launch Mustang PTA Balloon Catheter 25
Eurocor Introduces New PTA Balloon Technology 25
Boston Scientific Introduces Sterling SL Balloon Catheter for
Treating PAD 26
Boston Scientific Rolls out Journey Guidewire for Peripheral
Angioplasty Procedures 26
Volcano to Launch Three Products in the US 26
TRT and NovaRay Medical Develop X-Ray Imaging System with
Nethras MPPA Devices 26
Abbott Introduces Omnilink® Elite Peripheral Stent System 27
Invatec Launches FiberNet® 27
Cook Medical Launches Zilver PTX Drug-Eluting Peripheral Stent 28
Abbott Unveils FoxCross™ PTA Catheter and HI-TORQUE Versacore™
Guide Wire 28
Invatec Unveils Tapered and Amphirion Balloons 28
Abbott Introduces VOYAGER™ NC Coronary Dilatation Catheter 29
Vascumed Introduces DIOR Paclitaxel-Coated Coronary Balloon
Dilatation Catheter 29
Invatec Introduces IN.PACT Amphirion Paclitaxel-eluting PTA
Balloon Catheter 30
Cook Medical Introduces New Products for PAD Treatment 30
Terumo Introduces Glidewire Advantage™ Peripheral Guide Wire 30
Cook Medical Unveils Advance PTX Balloon 31
Medtronic Launches Angioplasty Products on Rapid Exchange
Delivery System 31
Cordis Launches SLEEK™ and SAVVY® Long PTA Balloon Dilatation
Catheters 31
B. Braun Introduces SeQuent Please in Malaysia 31
Cook Medical Rolls Out Advance® 18LP PTA Balloon Dilatation
Catheter in North America 32
Invatec Releases REEF HP™ PTA Balloon Catheter in Europe 32

7. RECENT INDUSTRY ACTIVITY 33
FDA Rejects Angioplasty Test of Nanosphere 33
Terumo Corporation Signs Supply Agreement with Kaneka Subsidiary 33
Asahi Intecc and Terumo Join Hands to Develop Medical Guidewire 33
Hotspur Secures FDA Approval for its First Three Commercial
Products 33
Angioslide Secures FDA Clearance for eXtra Angioplasty Balloon
Catheter 34
Opto Circuits Receives European Approval for Marketing Drug
Eluting Stent 34
Volcano Enters into Distribution Agreement with AngioScore 34
Volcano Acquires Xtract™ Thrombus Range from Lumen Biomedical 34
Boston Scientific Obtains FDA Approval for NC Quantum Apex
Balloon Catheter 35
Medtronic Acquires Invatec and Associated Companies 35
Avinger Merges with Sawtooth Labs 35
Medrad and B Braun Sign Co-Marketing and Trademark License
Agreement 36
Invatec and Cardiovascular Systems Sign Strategic Distribution
Agreement 36
ClearStream Obtains Approval for Marketing Peripheral
Angioplasty Balloon 36
AngioScore Receives Approval for AngioSculpt in Japan 36
Minnow Medical Obtains Approval for Disposable Catheter 37
MAQUET' MEGA™ Intra-Aortic Balloon Catheter Receives CE Mark 37
FDA Grants Clearance to Cook's Advance® 35LP PTA Balloon
Dilation Catheter 37
Invatec Obtains CE Mark for IN.PACT™ Admiral Drug Eluting
Balloon Catheter 38
Invatec Receives CE Mark for IN.PACT Falcon Paclitaxel-Eluting
PTCA Balloon Catheter 38

8. FOCUS ON SELECT GLOBAL PLAYERS 39
Abbott Vascular (US) 39
Boston Scientific Corporation (US) 39
C. R. Bard, Inc. (US) 40
Cordis Corporation (US) 41
Goodman Co., Ltd. (Japan) 41
Medtronic, Inc. (US) 42
Terumo Corporation (Japan) 42

9. GLOBAL MARKET PERSPECTIVE 43
Table 6: World Recent Past, Current, and Future Analysis for
Percutaneous Transluminal Coronary Angioplasty (PTCA) Products
by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific, Latin America and Rest of World Markets
Independently Analyzed with Annual Sales in US$ Million for
Years 2009 through 2017 (includes corresponding Graph/Chart) 43

Table 7: World Historic Review for Percutaneous Transluminal
Coronary Angioplasty (PTCA) Products by Geographic Region -
US, Canada, Japan, Europe, Asia-Pacific, Latin America and
Rest of World Markets Independently Analyzed with Annual Sales
in US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) 44

Table 8: World 15-Year Perspective for Percutaneous
Transluminal Coronary Angioplasty (PTCA) Products by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia-Pacific, Latin America and
Rest of World Markets for Years 2003, 2010 and 2017 (includes
corresponding Graph/Chart) 45

Table 9: World Recent Past, Current, and Future Analysis for
PTCA Balloon Catheters by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific, Latin America and Rest of World
Markets Independently Analyzed with Annual Sales in US$
Million for Years 2009 through 2017 (includes corresponding
Graph/Chart) 46

Table 10: World Historic Review for PTCA Balloon Catheters by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific,
Latin America and Rest of World Markets Independently Analyzed
with Annual Sales in US$ Million for Years 2003 through 2008
(includes corresponding Graph/Chart) 47

Table 11: World 15-Year Perspective for PTCA Balloon Catheters
by Geographic Region - Percentage Breakdown of Dollar Sales
for US, Canada, Japan, Europe, Asia-Pacific, Latin America and
Rest of World Markets for Years 2003, 2010 and 2017 (includes
corresponding Graph/Chart) 48

Table 12: World Recent Past, Current, and Future Analysis for
PTCA Guiding Catheters by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific, Latin America and Rest of World
Markets Independently Analyzed with Annual Sales in US$
Million for Years 2009 through 2017 (includes corresponding
Graph/Chart) 49

Table 13: World Historic Review for PTCA Guiding Catheters by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific,
Latin America and Rest of World Markets Independently Analyzed
with Annual Sales in US$ Million for Years 2003 through 2008
(includes corresponding Graph/Chart) 50

Table 14: World 15-Year Perspective for PTCA Guiding Catheters
by Geographic Region - Percentage Breakdown of Dollar Sales
for US, Canada, Japan, Europe, Asia-Pacific, Latin America and
Rest of World Markets for Years 2003, 2010 and 2017 (includes
corresponding Graph/Chart) 51

Table 15: World Recent Past, Current, and Future Analysis for
PTCA Guide Wires by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific, Latin America and Rest of World Markets
Independently Analyzed with Annual Sales in US$ Million for
Years 2009 through 2017 (includes corresponding Graph/Chart) 52

Table 16: World Historic Review for PTCA Guide Wires by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific,
Latin America and Rest of World Independently Analyzed with
Annual Sales in US$ Million for Years 2003 through 2008
(includes corresponding Graph/Chart) 53

Table 17: World 15-Year Perspective for PTCA Guide Wires by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia-Pacific, Latin America and
Rest of World Markets for Years 2003, 2010 and 2017 (includes
corresponding Graph/Chart) 54

10. THE UNITED STATES 55
A.Market Analysis 55
Coronary Heart Disease - A Leading Cause of Mortality in the US 55
Angioplasty - The Most Opted Procedure for Treating CHD in
the US 55
Table 18: US Angioplasty Procedural Volume in Thousands:
2009-2012 (includes corresponding Graph/Chart) 56
Angioplasty - More Beneficial in Acute Cases 56
Peripheral Interventional Market Trails High Growth 57
FDA Reclassifies PTCA Device Status and Drafts Guidance 57
Market Snippets 58
Table 19: US Drug-Eluting Stents Market (2009-2012): Market
Share Breakdown of Value Sales for Boston Scientific,
Abbott Laboratories, Medtronic, and Johnson & Johnson
(includes corresponding Graph/Chart) 58
Product Launches 58
Strategic Corporate Developments 63
Focus on Select Key Players 66
B.Market Analytics 70
Table 20: The US Recent Past, Current, and Future Analysis
for Percutaneous Transluminal Coronary Angioplasty (PTCA)
Products by Product Type - Balloon Catheters, Guiding
Catheters, and Guide Wires Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2009
through 2017 (includes corresponding Graph/Chart) 70

Table 21: The US Historic Review for Percutaneous
Transluminal Coronary Angioplasty (PTCA) Products by Product
Type - Balloon Catheters, Guiding Catheters, and Guide Wires
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) 71

Table 22: The US 15-Year Perspective for Percutaneous
Transluminal Coronary Angioplasty (PTCA) Products by Product
Type - Percentage Breakdown of Dollar Sales for Balloon
Catheters, Guiding Catheters, and Guide Wires Markets for
Years 2003, 2010 and 2017 (includes corresponding
Graph/Chart) 72

11. CANADA 73
A.Market Analysis 73
Angioplasty Procedural Volume Rises in Canada 73
Improved Access to Angioplasty Centers in Canada 73
Angioplasty Procedural Costs in Canada - A Recent Past Review 74
Table 23: Snowballing Effect of Cost Factors on Angioplasty
Hospital Costs in Canada: 2005-2006 (includes corresponding
Graph/Chart) 74
Voices Against Extensive Use of Angioplasty Echo in Canada 75
B.Market Analytics 76
Table 24: Canadian Recent Past, Current, and Future Analysis
for Percutaneous Transluminal Coronary Angioplasty (PTCA)
Products by Product Type - Balloon Catheters, Guiding
Catheters, and Guide Wires Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2009
through 2017 (includes corresponding Graph/Chart) 76

Table 25: Canadian Historic Review for Percutaneous
Transluminal Coronary Angioplasty (PTCA) Products by Product
Type - Balloon Catheters, Guiding Catheters, and Guide Wires
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) 77

Table 26: Canadian 15-Year Perspective for Percutaneous
Transluminal Coronary Angioplasty (PTCA) Products by Product
Type - Percentage Breakdown of Dollar Sales for Balloon
Catheters, Guiding Catheters, and Guide Wires Markets for
Years 2003, 2010 and 2017 (includes corresponding
Graph/Chart) 78

12. JAPAN 79
A.Market Analysis 79
Government's Efforts to Curb Prices of IC Devices 79
Simplified Regulations and Indication Specific Approvals
Bring Pace in Peripheral Vascular Stent Market 79
Competitive Landscape 80
Terumo Leads Japanese PTCA Balloon Catheter Market 80
Competition in Japanese Drug-Eluting Stents Market 80
Table 27: Japanese Drug-Eluting Stents Market (2009-2012):
Market Share Breakdown of Value Sales for Abbott
Laboratories, Boston Scientific, Medtronic, Johnson &
Johnson and Others (includes corresponding Graph/Chart) 80
Product Launch 81
Strategic Corporate Developments 81
Focus on Select Key Players 82
B.Market Analytics 83
Table 28: Japanese Recent Past, Current, and Future Analysis
for Percutaneous Transluminal Coronary Angioplasty (PTCA)
Products by Product Type - Balloon Catheters, Guiding
Catheters, and Guide Wires Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2009
through 2017 (includes corresponding Graph/Chart) 83

Table 29: Japanese Historic Review for Percutaneous
Transluminal Coronary Angioplasty (PTCA) Products by Product
Type - Balloon Catheters, Guiding Catheters, and Guide Wires
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) 84

Table 30: Japanese 15-Year Perspective for Percutaneous
Transluminal Coronary Angioplasty (PTCA) Products by Product
Type - Percentage Breakdown of Dollar Sales for Balloon
Catheters, Guiding Catheters, and Guide Wires Markets for
Years 2003, 2010 and 2017 (includes corresponding
Graph/Chart) 85

13. EUROPE 86
A.Market Analysis 86
CHD In Europe - An Overview on Disease Statistics 86
Demographic Factors Boost Market Growth 86
Inconsistency in Drug-Eluting Balloon Approval Procedure
Beleaguers Manufacturers 87
Product Launches 87
Strategic Corporate Developments 88
B.Market Analytics 91
Table 31: European Recent Past, Current, and Future Analysis
for Percutaneous Transluminal Coronary Angioplasty (PTCA)
Products by Geographic Region - France, Germany, Italy, UK
and Rest of Europe Markets Independently Analyzed with
Annual Sales in US$ Million for Years 2009 through 2017
(includes corresponding Graph/Chart) 91

Table 32: European Historic Review for Percutaneous
Transluminal Coronary Angioplasty (PTCA) Products by
Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets Independently Analyzed with Annual Sales in
US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) 92

Table 33: European 15-Year Perspective for Percutaneous
Transluminal Coronary Angioplasty (PTCA) Products by
Geographic Region - Percentage Breakdown of Dollar Sales for
France, Germany, Italy, UK and Rest of Europe Markets for
Years 2003, 2010 and 2017 (includes corresponding
Graph/Chart) 93

Table 34: European Recent Past, Current, and Future Analysis
for Percutaneous Transluminal Coronary Angioplasty (PTCA)
Products by Product Type - Balloon Catheters, Guiding
Catheters, and Guide Wires Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2009
through 2017 (includes corresponding Graph/Chart) 94

Table 35: European Historic Review for Percutaneous
Transluminal Coronary Angioplasty (PTCA) Products by Product
Type - Balloon Catheters, Guiding Catheters, and Guide Wires
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) 95

Table 36: European 15-Year Perspective for Percutaneous
Transluminal Coronary Angioplasty (PTCA) Products by Product
Type - Percentage Breakdown of Dollar Sales for Balloon
Catheters, Guiding Catheters, and Guide Wires Markets for
Years 2003, 2010 and 2017 (includes corresponding
Graph/Chart) 96

13a. FRANCE 97
Market Analysis 97
Table 37: French Recent Past, Current, and Future Analysis
for Percutaneous Transluminal Coronary Angioplasty (PTCA)
Products by Product Type - Balloon Catheters, Guiding
Catheters, and Guide Wires Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2009
through 2017 (includes corresponding Graph/Chart) 97

Table 38: French Historic Review for Percutaneous
Transluminal Coronary Angioplasty (PTCA) Products by Product
Type - Balloon Catheters, Guiding Catheters, and Guide Wires
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) 98

Table 39: French 15-Year Perspective for Percutaneous
Transluminal Coronary Angioplasty (PTCA) Products by Product
Type - Percentage Breakdown of Dollar Sales for Balloon
Catheters, Guiding Catheters, and Guide Wires Markets for
Years 2003, 2010 and 2017 (includes corresponding
Graph/Chart) 99

13b. GERMANY 100
A.Market Analysis 100
Product Launch 100
Strategic Corporate Development 101
B.Market Analytics 102
Table 40: German Recent Past, Current, and Future Analysis
for Percutaneous Transluminal Coronary Angioplasty (PTCA)
Products by Product Type - Balloon Catheters, Guiding
Catheters, and Guide Wires Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2009
through 2017 (includes corresponding Graph/Chart) 102

Table 41: German Historic Review for Percutaneous
Transluminal Coronary Angioplasty (PTCA) Products by Product
Type - Balloon Catheters, Guiding Catheters, and Guide Wires
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) 103

Table 42: German 15-Year Perspective for Percutaneous
Transluminal Coronary Angioplasty (PTCA) Products y Product
Type - Percentage Breakdown of Dollar Sales for Balloon
Catheters, Guiding Catheters, and Guide Wires Markets for
Years 2003, 2010 and 2017 (includes corresponding
Graph/Chart) 104

13c. ITALY 105
Market Analysis 105
Table 43: Italian Recent Past, Current, and Future Analysis
for Percutaneous Transluminal Coronary Angioplasty (PTCA)
Products by Product Type - Balloon Catheters, Guiding
Catheters, and Guide Wires Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2009
through 2017 (includes corresponding Graph/Chart) 105

Table 44: Italian Historic Review for Percutaneous
Transluminal Coronary Angioplasty (PTCA) Products by Product
Type - Balloon Catheters, Guiding Catheters, and Guide Wires
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) 106

Table 45: Italian 15-Year Perspective for Percutaneous
Transluminal Coronary Angioplasty (PTCA) Products by Product
Type - Percentage Breakdown of Dollar Sales for Balloon
Catheters, Guiding Catheters, and Guide Wires Markets for
Years 2003, 2010 and 2017 (includes corresponding
Graph/Chart) 107

13d. THE UNITED KINGDOM 108
A.Market Analysis 108
Increasing Popularity of Angioplasty Procedures through
Radial Artery 108
CHD - A Menacing Disease in the UK 108
Table 46: Number of People Affected with CHD in the UK by
Country: 2008-2009 (includes corresponding Graph/Chart) 109

Table 47: Prevalence of CHD in England by Age Group and
Gender (2006) (includes corresponding Graph/Chart) 109
CHD Related Mortality on the Decline 109
Product Launch 110
B.Market Analytics 111
Table 48: The UK Recent Past, Current, and Future Analysis
for Percutaneous Transluminal Coronary Angioplasty (PTCA)
Products by Product Type - Balloon Catheters, Guiding
Catheters, and Guide Wires Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2009
through 2017 (includes corresponding Graph/Chart) 111

Table 49: The UK Historic Review for Percutaneous
Transluminal Coronary Angioplasty (PTCA) Products by Product
Type - Balloon Catheters, Guiding Catheters, and Guide Wires
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) 112

Table 50: The UK 15-Year Perspective for Percutaneous
Transluminal Coronary Angioplasty (PTCA) Products by Product
Type - Percentage Breakdown of Dollar Sales for Balloon
Catheters, Guiding Catheters, and Guide Wires Markets for
Years 2003, 2010 and 2017 (includes corresponding
Graph/Chart) 113

13e. REST OF EUROPE 114
Market Analysis 114
Table 51: Rest of European Recent Past, Current, and Future
Analysis for Percutaneous Transluminal Coronary Angioplasty
(PTCA) Products by Product Type - Balloon Catheters, Guiding
Catheters, and Guide Wires Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2009
through 2017 (includes corresponding Graph/Chart) 115

Table 52: Rest of European Historic Review for Percutaneous
Transluminal Coronary Angioplasty (PTCA) Products by Product
Type - Balloon Catheters, Guiding Catheters, and Guide Wires
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) 116

Table 53: Rest of European 15-Year Perspective for
Percutaneous Transluminal Coronary Angioplasty (PTCA)
Products by Product Type - Percentage Breakdown of Dollar
Sales for Balloon Catheters, Guiding Catheters, and Guide
Wires Markets for Years 2003, 2010 and 2017 (includes
corresponding Graph/Chart) 117

14. ASIA-PACIFIC 118
A.Market Analysis 118
Rising Demand for Angioplasty Devices in China 118
Table 54: Unit Sales of PTCA Balloon Catheters in China by
Type (2005-2009) (includes corresponding Graph/Chart) 119
Foreign Companies Continue to Dominate Chinese PTCA Balloon
Market 119
CHD in Australia - An Overview of Disease Statistics in the
Country 120
Strong Growth Ahead for IC Devices 120
Product Launch 120
Strategic Corporate Development 121
B.Market Analytics 122
Table 55: Asia-Pacific Recent Past, Current, and Future
Analysis for Percutaneous Transluminal Coronary Angioplasty
(PTCA) Products by Product Type - Balloon Catheters, Guiding
Catheters, and Guide Wires Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2009
through 2017 (includes corresponding Graph/Chart) 122

Table 56: Asia-Pacific Historic Review for Percutaneous
Transluminal Coronary Angioplasty (PTCA) Products by Product
Type - Balloon Catheters, Guiding Catheters, and Guide Wires
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) 123

Table 57: Asia-Pacific 15-Year Perspective for Percutaneous
Transluminal Coronary Angioplasty (PTCA) Products by Product
Type - Percentage Breakdown of Dollar Sales for Balloon
Catheters, Guiding Catheters, and Guide Wires Markets for
Years 2003, 2010 and 2017 (includes corresponding
Graph/Chart) 124

15. LATIN AMERICA 125
A.Market Analysis 125
Steady Growth Ahead for Latin American IC Devices Market 125
Brazilian DES Market Suffers Due to Non-Reimbursement Policy
in Public Healthcare System 125
B.Market Analytics 127
Table 58: Latin American Recent Past, Current, and Future
Analysis for Percutaneous Transluminal Coronary Angioplasty
(PTCA) Products by Product Type - Balloon Catheters, Guiding
Catheters, and Guide Wires Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2009
through 2017 (includes corresponding Graph/Chart) 127

Table 59: Latin American Historic Review for Percutaneous
Transluminal Coronary Angioplasty (PTCA) Products by Product
Type - Balloon Catheters, Guiding Catheters, and Guide Wires
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) 128

Table 60: Latin American 15-Year Perspective for
Percutaneous Transluminal Coronary Angioplasty (PTCA)
Products by Product Type - Percentage Breakdown of Dollar
Sales for Balloon Catheters, Guiding Catheters, and Guide
Wires Markets for Years 2003, 2010 and 2017 (includes
corresponding Graph/Chart) 129

16. REST OF WORLD 130
Market Analysis 130
Table 61: Rest of World Recent Past, Current, and Future
Analysis for Percutaneous Transluminal Coronary Angioplasty
(PTCA) Products by Product Type - Balloon Catheters, Guiding
Catheters, and Guide Wires Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2009
through 2017 (includes corresponding Graph/Chart) 131

Table 62: Rest of World Historic Review for Percutaneous
Transluminal Coronary Angioplasty (PTCA) Products by Product
Type - Balloon Catheters, Guiding Catheters, and Guide Wires
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) 132

Table 63: Rest of World 15-Year Perspective for Percutaneous
Transluminal Coronary Angioplasty (PTCA) Products by Product
Type - Percentage Breakdown of Dollar Sales for Balloon
Catheters, Guiding Catheters, and Guide Wires Markets for
Years 2003, 2010 and 2017 (includes corresponding
Graph/Chart) 133

COMPETITIVE LANDSCAPE

Total Companies Profiled: 34 (including Divisions/Subsidiaries - 38)
  • -----------------------------------------
Region/Country Players
  • -----------------------------------------
The United States 24
Japan 3
Europe 9
France 1
Germany 4
The United Kingdom 1
Italy 2
Rest of Europe 1
Asia-Pacific (Excluding Japan) 2
  • -----------------------------------------
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
    Note: Product cover images may vary from those shown
    5 of 4
    Note: Product cover images may vary from those shown
    Adroll
    adroll